US 12173069
Antibodies binding to vista at acidic pH
granted A61KA61K2039/507A61K38/16
Quick answer
US patent 12173069 (Antibodies binding to vista at acidic pH) held by Five Prime Therapeutics, Inc. expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/507, A61K38/16